Triggering neurotrophic factor actions through adenosine A2A receptor activation: Implications for neuroprotection

British Journal of Pharmacology

Volumn 158, Issue 1, 2009, Pages 15-22

  Sebastião, Ana M ^a   Ribeiro, Joaquim A ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

A2A receptors; Adenosine; Alzheimer's disease; Brain derived neurotrophic factor; Hungtington's disease; Neurodegenerative diseases; Neurotrophic factors; Parkinson's disease

Indexed keywords

ADENOSINE; ADENOSINE A2A RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; G PROTEIN COUPLED RECEPTOR; NEURITE PROMOTING FACTOR; NEUROTROPHIC FACTOR; PROTEIN TYROSINE KINASE; TROPOMYOSIN;

AGING; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; EXCITOTOXICITY; GLIA CELL; HUMAN; MOLECULAR INTERACTION; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; POSTSYNAPTIC POTENTIAL; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

ANIMALS; HUMANS; NERVE GROWTH FACTORS; NEURODEGENERATIVE DISEASES; NEURONS; NEUROPROTECTIVE AGENTS; RECEPTOR, ADENOSINE A2A; SIGNAL TRANSDUCTION;

EID: 69249202366     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00157.x     Document Type: Review

References (84)

1. Balkowiec A, Katz D (2002). Cellular mechanisms regulating activity-dependent release of native brain-derived neurotrophic factor from hippocampal neurons. J Neurosci 22 : 10399 10407.
2. Baquet ZC, Gorski JA, Jones KR (2004). Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J Neurosci 24 : 4250 4258.
3. Bekar L, Libionka W, Tian GF, Xu Q, Torres A, Wang X et al. (2008). Adenosine is crucial for deep brain stimulation-mediated attenuation of tremor. Nat Med 14 : 17 19.
4. Bespalov MM, Saarma M (2007). GDNF family receptor complexes are emerging drug targets. Trends Pharmacol Sci 28 : 68 74.
5. Blöchl A, Blöchl R (2007). A cell-biological model of p75NTR signaling. J Neurochem 102 : 289 305.
6. Boulanger L, Poo M (1999a). Gating of BDNF-induced synaptic potentiation by cAMP. Science 284 : 1982 1984.
7. Boulanger L, Poo M (1999b). Presynaptic depolarization facilitates neurotrophin-induced synaptic potentiation. Nature Neurosci 2 : 346 351.
8. van Calker D, Müller M, Hamprecht B (1979). Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem 33 : 999 1005.
9. Castrén E, Võikar V, Rantamäki T (2007). Role of neurotrophic factors in depression. Curr Opin Pharmacol 7 : 18 21.
10. 2A antagonist KW6002 from animal models to Parkinsonian patients. Neurology 61 : S107 S111.
11. Cheng HC, Shih HM, Chern Y (2002). Essential role of cAMP-response element-binding protein activation by A2A adenosine receptors in rescuing the nerve growth factor-induced neurite outgrowth impaired by blockage of the MAPK cascade. J Biol Chem 277 : 33930 33942.
12. Chou SY, Lee YC, Chen HM, Chiang MC, Lai HL, Chang HH et al. (2005). CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model. J Neurochem 93 : 310 320.
13. Ciccarelli R, Di Iorio P, Bruno V, Battaglia G, D'Alimonte I, D'Onofrio M et al. (1999). Activation of A(1) adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100beta protein from cultured astrocytes. Glia 27 : 275 281.
14. Correia-de-Sá P, Timóteo MA, Ribeiro JA (1996). Presynaptic A1 inhibitory/A2A facilitatory adenosine receptor activation balance depends on motor nerve stimulation paradigm at the rat hemidiaphragm. J Neurophysiol 76 : 3910 3919.
15. Cunha RA, Constantino MC, Sebastião AM, Ribeiro JA (1995). Modification of A1 and A2a adenosine receptor binding in aged striatum, hippocampus and cortex of the rat. Neuroreport 6 : 1583 1588.
16. Cunha RA, Correia-de-Sá P, Sebastião AM, Ribeiro JA (1996). Preferential activation of excitatory adenosine receptors at rat hippocampal and neuromuscular synapses by adenosine formed from released adenine nucleotides. Br J Pharmacol 119 : 253 260.
17. Daré E, Schulte G, Karovic O, Hammarberg C, Fredholm BB (2007). Modulation of glial cell functions by adenosine receptors. Physiol Behav 92 : 15 20.
18. Diógenes MJ, Fernandes CC, Sebastião AM, Ribeiro JA (2004). Activation of adenosine A2A receptor facilitates brain-derived neurotrophic factor modulation of synaptic transmission in hippocampal slices. J Neurosci 24 : 2905 2913.
19. Diógenes MJ, Assaife-Lopes N, Pinto-Duarte A, Ribeiro JA, Sebastião AM (2007). Influence of age on BDNF modulation of hippocampal synaptic transmission, interplay with adenosine A2A receptors. Hippocampus 17 : 577 585.
20. Fernandes CC, Pinto-Duarte A, Ribeiro JA, Sebastião AM (2008). Postsynaptic action of brain-derived neurotrophic factor attenuates alpha7 nicotinic acetylcholine receptor-mediated responses in hippocampal interneurons. J Neurosci 28 : 5611 5618.
21. Ferré S, von Euler G, Johansson B, Fredholm BB, Fuxe K (1991). Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc Natl Acad Sci USA 88 : 7238 7241.
22. Ferré S, Ciruela F, Woods AS, Lluis C, Franco R (2007). Functional relevance of neurotransmitter receptor heteromers in the central nervous system. Trends Neurosci 30 : 440 446.
23. Ferreira JM, Paes-de-Carvalho R (2001). Long-term activation of adenosine A(2a) receptors blocks glutamate excitotoxicity in cultures of avian retinal neurons. Brain Res 900 : 169 176.
24. Fields RD, Burnstock G (2006). Purinergic signalling in neuron-glia interactions. Nat Rev Neurosci 7 : 423 436.
25. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (2001). International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53 : 527 552.
26. Fontinha BM, Diógenes MJ, Ribeiro JA, Sebastião AM (2008). Enhancement of long-term potentiation by brain-derived neurotrophic factor requires adenosine A(2A) receptor activation by endogenous adenosine. Neuropharmacology 54 : 924 933.
27. Fowler JC (1993). Changes in extracellular adenosine levels and population spike amplitude during graded hypoxia in the rat hippocampal slice. Naunyn Schmiedebergs Arch Pharmacol 347 : 73 78.
28. Frenguelli BG, Wigmore G, Llaudet E, Dale N (2007). Temporal and mechanistic dissociation of ATP and adenosine release during ischaemia in the mammalian hippocampus. J Neurochem 101 : 1400 1413.
29. Gauthier LR, Charrin BC, Borrell-Pagès M, Dompierre JP, Rangone H, Cordelières FP et al. (2004). Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118 : 127 138.
30. Golder FJ, Ranganathan L, Satriotomo I, Hoffman M, Lovett-Barr MR, Watters JJ et al. (2008). Spinal adenosine A2a receptor activation elicits long-lasting phrenic motor facilitation. J Neurosci 28 : 2033 2042.
31. Golembiowska K, Dziubina A (2004). Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats. Neuropharmacology 47 : 414 426.
32. Gomes CA, Vaz SH, Ribeiro JA, Sebastião AM (2006). Glial cell line-derived neurotrophic factor (GDNF) enhances dopamine release from striatal nerve endings in an adenosine A2A receptor-dependent manner. Brain Res 1113 : 129 136.
33. Gomes CA, Simões PF, Canas PM, Quiroz C, Sebastião AM, Ferré S et al. (2009). GDNF control of the glutamatergic cortico-striatal pathway requires tonic activation of adenosine A receptors. J Neurochem 108 : 1208 1219.
34. Gray R, Rajan AS, Radcliffe KA, Yakehiro M, Dani JA (1996). Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383 : 713 716.
35. Halassa MM, Fellin T, Haydon PG (2007). The tripartite synapse, roles for gliotransmission in health and disease.Trends. Mol Med 13 : 54 63.
36. Hartmann M, Heumann R, Lessmann V (2001). Synaptic secretion of BDNF after high-frequency stimulation of glutamatergic synapses. The EMBO Journal 20 : 5887 5897.
37. Heese K, Fiebich BL, Bauer J, Otten U (1997). Nerve growth factor (NGF) expression in rat microglia is induced by adenosine A2a-receptors. Neurosci Lett 231 : 83 86.
38. Huber A, Güttinger M, Möhler H, Boison D (2002). Seizure suppression by adenosine A(2A) receptor activation in a rat model of audiogenic brainstem epilepsy. Neurosci Lett 329 : 289 292.
39. Ji D, Lape R, Dani JA (2001). Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity. Neuron 31 : 131 141.
40. Kaplan DR, Miller FD (2000). Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 10 : 381 391.
41. Kaster MP, Rosa AO, Rosso MM, Goulart EC, Santos AR, Rodrigues AL (2004). Adenosine administration produces an antidepressant-like effect in mice: evidence for the involvement of A1 and A2A. receptorsNeurosci Lett 355 : 21 24.
42. Kozisek ME, Middlemas D, Bylund DB (2008). Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies. Pharmacol Ther 117 : 30 51.
43. Larson PS (2008). Deep brain stimulation for psychiatric disorders. Neurotherapeutics 5 : 50 58.
44. Latini S, Pedata F (2001). Adenosine in the central nervous system, release mechanisms and extracellular concentrations. J Neurochem 79 : 463 484.
45. Lee FS, Chao MV (2001). Activation of Trk neurotrophin receptors in the absence of neurotrophins. Proc Natl Acad Sci USA 98 : 3555 3560.
46. Lee FS, Rajagopal R, Chao MV (2002). Distinctive features of Trk neurotrophin receptor transactivation by G protein-coupled receptors. Cytokine Growth Factor Rev 13 : 11 17.
47. Lewin GR, Barde Y-A (1996). Physiology of the neurotrophins. Annu Rev. Neuroscience 19 : 289 317.
48. Li T, Steinbeck JA, Lusardi T, Koch P, Lan JQ, Wilz A Segschneider M et al. (2007). Suppression of kindling epileptogenesis by adenosine releasing stem cell derived brain implants. Brain 130 : 1276 1288.
49. Love S, Plaha P, Patel NK, Hotton GR, Brooks DJ, Gill SS (2005). Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain. Nat Med 11 : 703 704.
50. McAllister AK, Katz LC, Lo DC (1999). Neurotrophins and synaptic plasticity. Annu Ver Neurosci 22 : 295 318.
51. de Mendonça A, Sebastião AM, Ribeiro JA (2000). Adenosine, does it have a neuroprotective role after all? Brain Res Rev 33 : 258 274.
52. Mojsilovic-Petrovic J, Jeong GB, Crocker A, Arneja A, David S, Russell DS et al. (2006). Protecting motor neurons from toxic insult by antagonism of adenosine A2a and Trk receptors. J Neurosci 26 : 9250 9263.
53. Morelli M, Di Paolo T, Wardas J, Calon F, Xiao D, Schwarzschild MA (2007). Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complications. Prog Neurobiol 83 : 293 309.
54. Murer MG, Yan Q, Raisman-Vozari R (2001). Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 63 : 71 124.
55. Nagappan G, Lu B (2005). Activity-dependent modulation of the BDNF receptor TrkB, mechanisms and implications. Trends Neurosci 28 : 464 471.
56. Nakamura M, Nakakimura K, Matsumoto M, Sakabe T (2002). Rapid tolerance to focal cerebral ischemia in rats is attenuated by adenosine A1 receptor antagonist. J Cereb Blood Flow Metab 22 : 161 170.
57. Patel NK, Bunnage M, Plaha P, Svendsen CN, Heywood P, Gill SS (2005). Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD, a two-year outcome study. Ann. Neurol 57 : 298 302.
58. Pazzagli M, Pedata F, Pepeu G (1993). Effect of K+ depolarization, tetrodotoxin, and NMDA receptor inhibition on extracellular adenosine levels in rat striatum. Eur J Pharmacol 234 : 61 65.
59. Pousinha PA, Diogenes MJ, Ribeiro JA, Sebastião AM (2006). Triggering of BDNF facilitatory action on neuromuscular transmission by adenosine A2A receptors. Neurosci Lett 404 : 143 147.
60. Potenza RL, Tebano MT, Martire A, Domenici MR, Pepponi R, Armida M et al. (2007). Adenosine A(2A) receptors modulate BDNF both in normal conditions and in experimental models of Huntington's disease. Purinergic Signal 3 : 333 338.
61. Pugliese AM, Latini S, Corradetti R, Pedata F (2003). Brief, repeated, oxygen-glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus, role of adenosine receptors. Br J Pharmacol 140 : 305 314.
62. Rajagopal R, Chen ZY, Lee FS, Chao MV (2004). Transactivation of Trk neurotrophin receptors by G-protein-coupled receptor ligands occurs on intracellular membranes. J Neurosci 24 : 6650 6658.
63. Rebola N, Sebastião AM, de Mendonca A, Oliveira CR, Ribeiro JA, Cunha RA (2003). Enhanced adenosine A2A receptor facilitation of synaptic transmission in the hippocampus of aged rats. J Neurophysiol 90 : 1295 1303.
64. Ribeiro JA, Sebastião AM, de Mendonça A (2003). Adenosine receptors in the nervous system, pathophysiological implications. Prog. Neurobiol 68 : 377 392.
65. Scharfman HE, Hen R (2007). Is more neurogenesis always better?. Science 315 : 336 338.
66. Schulte-Herbrüggen O, Braun A, Rochlitzer S, Jockers-Scherübl MC, Hellweg R (2007). Neurotrophic factors - a tool for therapeutic strategies in neurological, neuropsychiatric and neuroimmunological diseases?. Curr Med Chem 14 : 2318 2329.
67. Sebastião AM, Ribeiro JA (2000). Fine-tuning neuromodulation by adenosine. Trends Pharmacol Sci 21 : 341 346.
68. Sebastião AM, Ribeiro JA (2009). Adenosine receptors and the central nervous system. In : CN Wilson, SJ Mustafa (eds). Adenosine Receptors in Health and Disease, Handbook of Experimental Pharmacology 193. Springer-Verlag, Berlin Heidelberg. DOI 10.1007/978-3-540-89615-9-16
69. Sebastião AM, de Mendonça A, Moreira T, Ribeiro JA (2001). Activation of synaptic NMDA receptors by action potential-dependent release of transmitter during hypoxia impairs recovery of synaptic transmission on reoxygenation. J. Neurosci 21 : 8564 8571.
70. Silhol M, Bonnichon V, Rage F, Tapia-Arancibia L (2005). Age-related changes in brain-derived neurotrophic factor and tyrosine kinase receptor isoforms in the hippocampus and hypothalamus in male rats. Neuroscience 132 : 613 624.
71. Simonato M, Tongiorgi E, Kokaia M (2006). Angels and demons, neurotrophic factors and epilepsy. Trends Pharmacol Sci 27 : 631 638.
72. Stevens B, Porta S, Haak LL, Gallo V, Fields RD (2002). Adenosine, a neuron-glial transmitter promoting myelination in the CNS in response to action potentials. Neuron 36 : 855 868.
73. Stevens B, Ishibashi T, Chen JF, Fields RD (2004). Adenosine, an activity-dependent axonal signal regulating MAP kinase and proliferation in developing Schwann cells. Neuron Glia Biol 1 : 23 34.
74. Strand AD, Baquet ZC, Aragaki AK, Holmans P, Yang L, Cleren C et al. (2007). Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration. J Neurosci 27 : 11758 11768.
75. Tebano MT, Martire A, Potenza RL, Grò C, Pepponi R, Armida M et al. (2008). Adenosine A(2A) receptors are required for normal BDNF levels and BDNF-induced potentiation of synaptic transmission in the mouse hippocampus. J Neurochem 104 : 279 286.
76. Thevananther S, Rivera A, Rivkees SA (2001). A1 adenosine receptor activation inhibits neurite process formation by Rho kinase-mediated pathways. Neuroreport 12 : 3057 3063.
77. Thoenen H, Sendtner M (2002). Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nat Neurosci 5 (Suppl 1046 1050.
78. Vaz S, Cristóvão-Ferreira S, Ribeiro JA, Sebastiao AM (2008). Brain-derived neurotrophic factor inhibits GABA uptake by the rat hippocampal nerve terminals. Brain Res 1219 : 19 25.
79. Wieraszko A, Goldsmith G, Seyfried TN (1989). Stimulation-dependent release of adenosine triphosphate from hippocampal slices. Brain Research 485 : 244 250.
80. Wiese S, Jablonka S, Holtmann B, Orel N, Rajagopal R, Chao MV et al. (2007). Adenosine receptor A2A-R contributes to motoneuron survival by transactivating the tyrosine kinase receptor TrkB. Proc Natl Acad Sci USA 104 (43 17210 17215.
81. White JH, Wise A, Main MJ, Green A, Fraser NJ, Disney GH et al. (1998). Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature 396 : 679 682.
82. Yamagata K, Hakata K, Maeda A, Mochizuki C, Matsufuji H, Chino M et al. (2007). Adenosine induces expression of glial cell line-derived neurotrophic factor (GDNF) in primary rat astrocytes. Neurosci Res 59 : 467 474.
83. Zeraati M, Mirnajafi-Zadeh J, Fathollahi Y, Namvar S, Rezvani ME (2006). Adenosine A1 and A2A receptors of hippocampal CA1 region have opposite effects on piriform cortex kindled seizures in rats. Seizure 15 : 41 48.
84. Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L et al. (2001). Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 293 : 493 498.